Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis

RSEM output of RNA sequence of rheumatoid arthritis patients treated with abatacept. Sample names beginning with“R” indicate responders, “NR” indicates non-responders; sample names ending with“0 M” indicate pre-treatment, and“_3M” indicates 3 months post-treatment. If you use this date, please cite Iwasaki et al. https://doi.org/10.1186/s13075-023-03236-y